PERF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PERF is not a good buy right now. The stock is in a clear bearish trend (SMA_200 > SMA_20 > SMA_5) with weakening momentum (MACD histogram negative and expanding). With no near-term news catalysts, neutral institutional/insider activity, and a statistically negative forward-return profile (next month skew), the odds favor further downside rather than an immediate rebound. Given an impatient approach (unwilling to wait for optimal entries), the risk/reward is unfavorable at the current pre-market price (~1.65).
Trend/Momentum: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. MACD histogram (-0.00617) is below zero and negatively expanding, signaling accelerating downside momentum.
RSI: RSI_6 at ~27.95 is near oversold territory, which can allow short bounces, but in a strong downtrend oversold readings often persist and are not reliable buy signals by themselves.
Key levels (pre-market ~1.65): Pivot 1.677 is overhead (near-term resistance). Support is S1 1.604 then S2 1.56; a break below 1.604 would likely invite another leg down. Upside resistance levels: R1 1.75 and R2 1.794.
Pattern-based forward bias: Similar-candlestick model suggests a 60% probability of -1.54% next day, -1.67% next week, and -12.44% next month—skewing decisively bearish.
Intellectia Proprietary Trading Signals
Revenue growth remains solid: 2025/Q3 revenue rose 15.70% YoY, which can support valuation if margins/profits stabilize. RSI is near oversold (~28), which sometimes enables a short-lived technical bounce if support holds.
No news in the last week, so there are no clear event-driven catalysts to reverse the downtrend. Technicals are decisively bearish (bearish MA stack + worsening MACD). Pattern-based outlook is negative (model implies meaningful downside over the next month). Profitability weakened in the latest quarter (net income, EPS, and gross margin all down YoY), which can pressure sentiment.
Latest quarter: 2025/Q3. Revenue increased to 18.659M (+15.70% YoY), but profitability deteriorated: net income fell to 2.08M (-17.85% YoY) and EPS dropped to 0.02 (-33.33% YoY). Gross margin decreased to 75.82% (-5.63% YoY). Overall: top-line growth is positive, but margin/earnings compression is a negative trend.
No analyst rating or price target change data was provided, so a recent Wall Street consensus trend cannot be confirmed from this dataset. Practical pro view (inferred from fundamentals): strong revenue growth. Cons: declining EPS/margins and a bearish price trend, which typically limits near-term upside appetite. Trading trends show hedge funds and insiders are neutral, offering no supportive signal. Politician/congress activity: no recent congress trading data available.
